News & Events

The latest news and events from Embold Health.

Sort by Category

Embold Health announces new key hires to fuel growth and expansion

Embold Health, the industry leader in objective physician quality measurement, announced the appointment of two new key roles to continue to meet the needs of current clients and fuel growth and expansion into the future.

Partnership with SurgeryPlus® to deliver market-leading quality experience

Embold Health's initial assessment reveals physicians in the SurgeryPlus network surpass market peers in both care quality and cost-effectiveness.

Harvard Business Review: Managing a Polarized Workforce

Knowledge is power. And for your employees, knowing which doctor has the best waiting room gives nowhere near as much power as knowing which doctor is the least likely to perform unnecessary C-section surgery.

Embold Health named to the 2022 CB Insights’ Digital Health 150 List

Embold Health recognized for achievements in Interoperability, Data, and Analytics

Partnership with The Independent Colleges and Universities Benefits Association (ICUBA) to improve healthcare for members

Embold Health’s physician performance insights will improve healthcare quality, decrease unnecessary care, and reduce costs for ICUBA’s members.

Webinar: The elusive search for the "best doctor"

Embold Health hosted a webinar discussion with Walmart, Aon, and BayCare Health focusing on the elusive search for the “best” doctor.

Partnership with The Leapfrog Group provides hospital safety grades to members

Embold has incorporated Leapfrog data within their platform to provide members with hospital safety grades to easily identify the safest hospitals to receive care.

Senator Bill Frist’s “A Second Opinion” Podcast hosts Embold’s Dr. Stein to discuss raising the bar in healthcare

Finding a high-quality doctor is hard. Listen as Senator Bill Frist and Dr. Daniel Stein discuss one of the largest cost drivers in healthcare - variations in quality of care between doctors.

Dr. Daniel Stein featured on prestigious healthcare panel during Business Group on Health's 2022 annual conference

Dr. Daniel Stein joined a distinguished panel of healthcare professionals, including UnitedHealth Group Chief Medical Officer, Dr. Omar Baker, and Vanderbilt University Associate Professor of Economics, Dr. Larry Van Horn, for a lively and insightful discussion at the Business Group on Health’s Annual Conference on April 19-21, 2022, in Nashville, TN.

Partnership with Polk County Public Schools to improve quality of care for employees and their families

Embold Health, an industry leader in objective physician performance analytics, is partnering with Polk County Public Schools (PCPS), the seventh-largest school district in Florida and among the 30 largest in the country, to improve healthcare for its 14,000 employees and their families.

Dr. Daniel Stein chimes in on healthcare quality on Yale's Health and Veritas Podcast

On Yale's Health & Veritas podcast, Dr. Daniel Stein discusses healthcare quality measurement and overall system improvement.

$23M in Series B Funding to enable Embold’s continued growth

Morgan Health, the JPMorgan Chase & Co (NYSE: JPM) business focused on improving the quality, equity and affordability of employee healthcare, announced a $5 million investment in Embold Health, a physician-led analytics company that measures and creates transparency around provider performance.

Embold Health expands physician quality partnership with Walmart

Embold’s physician performance insights will help an additional 42,000 Walmart associates and their dependents find high-quality healthcare in their area.

Embold and Harvard publish in JAMA Health Forum: Significant physician variation exists within communities

Embold Health recently conducted a physician quality research study in collaboration with Harvard Medical School and other leading institutions.

Embold Health raises $20M in Series B Led by Echo Health Ventures

Embold Health, Inc, a leader in objective physician performance analytics, is excited to announce a Series B investment led by Echo Health Ventures.